(NYSEMKT: XTNT) Xtant Medical Holdings's forecast annual revenue growth rate of -1.75% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.4%.
Xtant Medical Holdings's revenue in 2025 is $133,083,000.On average, 4 Wall Street analysts forecast XTNT's revenue for 2025 to be $18,557,562,012, with the lowest XTNT revenue forecast at $17,301,723,979, and the highest XTNT revenue forecast at $19,669,195,678. On average, 4 Wall Street analysts forecast XTNT's revenue for 2026 to be $16,894,311,641, with the lowest XTNT revenue forecast at $14,323,833,794, and the highest XTNT revenue forecast at $19,433,988,554.
In 2027, XTNT is forecast to generate $18,500,160,274 in revenue, with the lowest revenue forecast at $15,641,273,693 and the highest revenue forecast at $21,331,046,006.